A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

November 30, 2012

Conditions
Huntington Disease
Interventions
DRUG

Memantine

oral tablet, 1 BID, 24 weeks

OTHER

Placebo

oral tablet, 1 BID, 24 weeks

Trial Locations (1)

V6T 2B5

The Centre for Huntington Disease, Vancouver

All Listed Sponsors
collaborator

Huntington Society of Canada

OTHER

collaborator

Huntington Study Group

NETWORK

lead

University of British Columbia

OTHER

NCT01458470 - A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease | Biotech Hunter | Biotech Hunter